MedPath

Multicenter Study to Evaluate the Clinical and Cost Effectiveness of a Youth Culturally Adapted Therapy (YCMAP)

Not Applicable
Completed
Conditions
Self Harm
Interventions
Behavioral: Youth Culturally Adapted Manual Assisted Psychological Therapy (Y-CMAP)
Registration Number
NCT04131179
Lead Sponsor
Pakistan Institute of Living and Learning
Brief Summary

To evaluate the clinical and cost-effectiveness of a youth culturally adapted manual assisted therapy (YCMAP) in Pakistani Adolescents with a history of self-harm

Detailed Description

Globally suicide is the second leading cause of death in young people 15-29 years of age. A recent review indicated that the reported suicide rates in South Asia are high compared to the global average. These figures are likely to be an under estimate since suicide data from many Low and Middle Income Countries (LMICs) is lacking. There is little official data on suicide from Pakistan, where suicide and self-harm remains as criminal act and socially, religiously condemned. However, there is accumulating evidence that both self-harm and suicide rates have been increasing in Pakistan.

This is the first RCT of a psychological intervention for self-harm in children and young people in Pakistan. It follows from the work of "Multicentre RCT to evaluate the clinical and cost effectiveness of culturally adapted manual assisted psychological intervention"(CMAP) trial currently taking place in adults who have self-harmed in Pakistan, by evaluating whether a similar intervention, adapted for children and adolescents, could be clinically and cost effective.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
684
Inclusion Criteria
  • Patients age 12-18 years presenting to the participating GPs, emergency departments or admitted after an episode of self-harm to the participating hospitals or self-referrals.
  • History of recent self-harm. Recent self-harm is defined as self-harm occurring within the last 3 months (from the initial identification of a potential participant).
  • Participants living within the catchment area of the participating practices and hospitals.
  • Not needing inpatient psychiatric treatment.
Exclusion Criteria
  • Severe mental illness (such as Psychotic disorder) as Self-harm commonly co- occurs with other mental health difficulties.
  • Conditions limiting engagement with assessment or intervention, including developmental and communication disorders, intellectual disabilities and autistic spectrum disorders.
  • Temporary resident unlikely to be available for follow up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Youth culturally adapted therapy (Y-CMAP)Youth Culturally Adapted Manual Assisted Psychological Therapy (Y-CMAP)Youth Culturally adapted manual assisted (Y-CMAP) psychological therapy
Primary Outcome Measures
NameTimeMethod
Suicide Attempt Self Injury Interview SASIIChange in scores from baseline to 12th months

Repetition rate of self-harm measured by adapted Suicide Attempt Self-Injury Interview (SASII). Higher number on repetition indicates worse outcome and vice versa

Secondary Outcome Measures
NameTimeMethod
Client Services Receipt Inventory CSRIChange in scores from Baseline to 3rd, 6th, 9th and 12th month.

We will collect information on the use of health services (including the informal sector such as faith healers/Imams)

Beck Scale for Suicidal ideation (BSI)Change in scores from Baseline to 3rd, 6th, 9th and 12th month.

Suicidal ideation will be assessed with the Beck Scale for Suicide Ideation (BSS; Beck \& Steer, 1991), a 19-item self-report questionnaire, measuring the intensity and frequency of suicidal thoughts within the past week. Minimum total score is 0 and maximum total score can be 38. Higher scores indicate worse outcome.

Psychological Distress ScaleChange in scores from Baseline to 3rd, 6th, 9th and 12th month.

It's a 10 item scale measuring emotional states with a 5 level response scale. The maximum score is 50 indicating severe distress, and the minimum score is 10 indicating no distress.

EuroQol-5 Dimensions (EQ5-D)Change in scores from Baseline to 3rd, 6th, 9th and 12th month.

A standardised instrument to measure health status and associated population utility weights. It consists of a self-report questionnaire covering five dimensions of health (mobility, self-care, usual activities, pain/ discomfort and anxiety/ depression).

Beck Hopelessness Scale[Time Frame: Baseline,3rd,6th,9th and 12th months]

This is a 20 items scale measuring hopelessness. Higher scores on the scale indicate greater severity of hopelessness. Minimum total score on this scale can be 0 and maximum total score can be 20, with higher levels of hopelessness indicated by higher scores on the scale.

Client Satisfaction Questionnaire (CSQ).Change in scores from Baseline to 3rd, 6th, 9th and 12th month.

The participants will rate their satisfaction with treatment by using the CSQ. The total score ranges from 8 to 32. Higher scores indicate higher level of satisfaction.

Trial Locations

Locations (3)

Lahore Site

🇵🇰

Lahore, Pakistan

Karachi Site

🇵🇰

Karachi, Sindh, Pakistan

Rawalpindi Site

🇵🇰

Rawalpindi, Pakistan

© Copyright 2025. All Rights Reserved by MedPath